In addition, unlike Ab-derived radiotracers, the 99mTc-HER2-NB tracer is designed not to target the same HER2 epitope as the therapeutic Abs, thus avoiding the effect that the circulating drug might have on tumor uptake. This evidence concerns the gene ERBB2 and neoplasm.